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To identify Chlamydia trachomatis genes involved in attachment to host cells, a chlamydial genomic library
was screened on the basis of binding characteristics by two methods. In the whole-cell screen, individual
recombinant Escherichia coli clones were assayed for adherence to eukaryotic cells. In the membrane-binding
screen, each recombinant colony of E. coli was treated with CHCI3 and assayed for binding to purified,
3-[(3-cholamidopropyl)-dimethyl-ammonio]-1-propanesulfonate (CHAPS)-solubilized, 35S-labeled eukaryotic
membrane material. Initial screening with McCoy ceUs was refined by using HEC-1B cells, a human
endometrial epithelial cell line, which discriminate among recombinants adhering to McCoy cells. Some
recombinants demonstrate significantly greater adherence to HEC-1B cells than to McCoy cells and appear, by
transmission electron microscopy, to associate with electron-dense areas of the epithelial cell plasma
membrane, resembling coated pits. Recombinants positive by one or both screening methods were examined by
Southern and Western (immunoblot) analyses, which revealed the presence of chlamydial sequences inserted
in the plasmids and the expression of novel 18-, 28-, and -82-kDa proteins, recognized by antichlamydial sera.
Maxicell analysis of selected recombinants confirmed that the proteins of 28 and -82 kDa, and perhaps of 18
kDa, are plasmid encoded. Antiserum generated against the recombinant -82-kDa protein reacted in Western
analysis with a similar-sized protein from C. trachomatis serovar E elementary bodies (EB) and reticulate
bodies, serovar L2 EB, and C. psittaci EB. E. coli JM109(pPBW58) contains a 6.7-kb plasmid insert which
encodes proteins of all three sizes. Under a number of different conditions in the whole-cell attachment
assay-i.e., at 4°C, in Ca2+- and Mg2+-free medium, in the presence of trypsin or dextran sulfate, and with
rabbit aortic endothelial cells-the binding specificity of JM109(pPBW58) parallels that of C. trachomatis EB.
Finally, the adherence phenotype of E. coli JM109(pPBW58) correlates directly with the presence of the
recombinant plasmid; the phenotype is lost concurrently with loss of the recombinant plasmid, and the
phenotype is acquired concurrent with reintroduction of the recombinant plasmid into E. coli JM109. The role
of the 18-, 28-, and -82-kDa proteins in mediating attachment, whether they act in concert as a complex or
individually, has yet to be determined.
In nature, the obligate intracellular bacterium Chlamydia
trachomatis demonstrates selectivity in the host organism
(humans) and the types of host cells infected. C. trachomatis
serovars A, B, Ba, and C infect conjunctival epithelia;
serovars D through K primarily infect urogenital epithelia,
though conjunctival and fetal bronchial epithelia are also
susceptible. The lymphogranuloma venereum biovar (C.
trachomatis serovars Li, L2, and L3) initially infects the
urogenital epithelial but then invades deeper tissue, demon-
strating a marked lymphotrophism. Cell selectivity in vivo
has a number of plausible explanations, which include
restriction to cell types to which the nonmotile, infectious C.
trachomatis elementary bodies (EB) are exposed, and re-
striction to cell types capable of supporting chlamydial
growth (30). Selective adherence only to cells capable of
supporting growth is more economical, and certainly, as the
processes of attachment and entry are of vital importance,
one might suppose that chlamydiae have evolved a strategy
to ensure their entry into the appropriate host cell.
Adherence and entry of Chlamydia spp. have been studied
by numerous investigators, and some findings suggest that
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macromolecules on the infectious EB and the host cell
participate in chlamydial attachment. Exposure of EB to
conditions and reagents which reduce adherence to tissue
culture cells include (i) exposure to heat (60°C) for 3 min, (ii)
periodate treatment, and (iii) acetic anhydride treatment (4,
14). Adherence of chlamydiae is also reduced by exposing
the tissue culture cells to periodate and trypsin; the effect of
the latter is reversible over time except in the presence of
cycloheximide, which inhibits eukaryotic protein synthesis
(4, 14). These data suggest that the EB and the host cell have
both surface carbohydrate and proteinaceous moieties, per-
haps glycoproteins, which are involved in chlamydial attach-
ment.
Several questions remain unanswered. (i) Do the treat-
ments mentioned above affect some global surface property,
such as charge or hydrophobicity, or are certain macro-
molecules, i.e., a chlamydial adhesin(s) and eukaryote
receptor(s), involved in specific interactions that mediate
attachment? (ii) Is chlamydial adherence a one-step process
or is it a multistep process in which electrostatic interactions
might mediate initial attachment but are followed by more
specific interactions (49)?
A role for electrostatic interactions is suggested by find-
ings that the polycation DEAE-dextran improves the infec-
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tivity of some serovars of C. trachomatis and that Ca2" or
Mg2+ is necessary for maximal adherence (14, 25). Since
both the eukaryotic cell surface and chlamydiae carry a net
negative charge, a formidable electrostatic barrier must be
overcome prior to attachment (39, 47). Indeed, in an elegant
study by Su et al. (44), the major outer membrane protein
(MOMP) is proposed to promote localized, nonspecific elec-
trostatic and hydrophobic interactions with the host cell.
They demonstrated that monoclonal antibodies to MOMP
surface-exposed epitopes in variable domains II and IV
block EB attachment to hamster kidney cells (43, 44). The
heat-sensitive loss of adherence of EB is correlated to a
heat-triggered conformational change in an inaccessible,
conserved, hydrophobic nonapeptide in the variable domain
IV region of MOMP.
Data which support a specific adhesion step include evi-
dence that (i) attachment of chlamydiae to HeLa or McCoy
cells is saturable at 4°C and different serovars of C. tracho-
matis competitively inhibit adherence of another serovar
(48) and (ii) chlamydiae can be internalized by the receptor-
mediated endocytosis pathway (15, 16, 36, 40). Investigators
have proposed that several chlamydial proteins are candi-
dates for adhesins. For example, a polypeptide of 27 to 32
kDa (the size depending on the serovar) was shown to bind
to isolated, radioiodinated HeLa cell membranes following
denaturation with sodium dodecyl sulfate (SDS) (10, 51).
Most recently, Swanson and Kuo (45) have discovered
lectin-binding activity in chlamydial polypeptides of 18 and
27 to 32 kDa; lectin binding is abolished when the chlamydial
proteins are treated with periodate. Joseph and Bose (19)
have proposed that another protein, a 38-kDa "cytadhesin,"
is involved in chlamydial adherence. Of all the proteins
solubilized in n-octyl-,B-D-glucopyranoside extracts of whole
EB, including the MOMP, 18-, and -32-kDa proteins, only
the 38-kDa protein was shown to bind specifically to glut-
araldehyde-fixed HeLa cells at 4°C and not to bind to the
plastic culture vessel. Both heating and trypsin treatment of
the extract interfered with binding of the 38-kDa protein to
host cells and resulted in a loss of competitive inhibition in
the attachment of EB to host cells.
This study adopts a functional approach for identification
of chlamydial adherence determinants, to either substantiate
previous work or discover as yet unrecognized chlamydial
adhesins. The 1,600 recombinant E. coli clones obtained
from a C. trachomatis (serovar E) genomic library (pUC19)
were screened individually by two assays. (i) Each recom-
binant was carefully examined for adherence to McCoy and
subsequently to HEC-1B cell monolayers to determine
whether expressed proteins of chlamydial origin could con-
fer adherence to the normally nonadherent strain of E. coli.
(ii) In the event that chlamydial proteins expressed in the
recombinant could not be properly exported to and folded on
the surface of E. coli, chloroform-exposed colonies of each
recombinant were assayed for eukaryotic membrane-binding
activity by incubation with 35S-labeled eukaryotic mem-
brane. Several recombinants that were positive by one or
both methods are indeed producing novel proteins of chla-
mydial origin.
MATERIALS AND METHODS
Bacterial strains and culture methods. C. trachomatis
E/UW-5/CX (obtained from C. C. Kuo and S. P. Wang,
University of Washington) was grown in McCoy cells and
purified, and the titer was determined as described previ-
ously (33). Reticulate bodies (RB) were purified by an
adaptation of the endosome purification procedure of Mat-
sumoto (31) followed by standard Renografin density cen-
trifugation. The HEC-1B cell line used in screening and
functional assays was propagated from a human endometrial
adenocarcinoma (26). McCoy and HEC-1B cells were cul-
tured in Eagle's minimum essential medium (MEM) with
10% heat-inactivated bovine calf serum. E. coli JM109
[recAl endAl gyrA96 thi hsdRJ7 [rK- MK+] relAl supE44 A-
A(lac-proAB) (F- traD36 proAB lacIqZVM15)] (53), JM109
(pUC19), and recombinants were grown at 37°C in Luria
broth (LB) or on Luria plates with ampicillin (200 ,ug/ml) for
plasmid-containing strains. Mid-log-phase bacteria were fro-
zen in LB with 20% glycerol to generate freezer stock
cultures.
Chiamydial DNA and plasmid preparation. Approximately
0.5 x 1010 to 5 x 1010 purified EB were used to isolate
chlamydial genomic DNA as described previously (22).
Generally, the purified genomic DNA fragments were
greater than 50 kb in length, as determined by electrophore-
sis in a 0.3% agarose gel. pUC19 (53) and recombinant
plasmids were isolated from E. coli by the alkaline lysis
method of Birnboim and Doly (2) and CsCl gradient centrif-
ugation.
Creation of a C. trachomatis genomic library. The pUC19
vector was chosen because (i) a complete genomic library
could be generated with <2,000 recombinants and (ii) pUC
vectors were successfully used to isolate chlamydial genes
encoding outer membrane proteins and an enzyme which
were stably expressed and functional, respectively, in E. coli
(5, 34). A partial Sau3AI digest of C. trachomatis serovar E
DNA was size fractionated on a 0.7% agarose gel. Frag-
ments of 5 to 12 kb in length were electroeluted and ligated
into pUC19, which had been digested with BamHI and then
dephosphorylated with calf alkaline phosphatase. Strain
JM109 was made competent for transformation by the rubid-
ium chloride method of Hanahan (13). Aliquots of the
ligation reaction mixes were incubated with competent
JM109 for 30 min on ice, then heated for 2 min at 42°C, and
incubated for 90 min at 37°C. The bacteria were plated on LB
plates containing ampicillin (100 ,ug/ml) and X-gal (5-bromo-
4-chloro-3-indolyl-p-D-galactoside) (20 ,ug/ml) and incubated
for 16 h at 37°C. Recombinant colonies were selected on the
basis of insertional inactivation of the alpha fragment of
3-galactosidase on the plasmids, as determined by using the
lactose analog X-gal. The vector, pUC19, did not require
induction of the lac promoter (lacZp) by IPTG (lactose
analog; isopropyl-1-thio-D-galactoside) to distinguish an ac-
tive alpha fragment in the presence of X-gal. Apparently, the
lac repressor does not completely stop transcription from
lacZp on a high-copy-number plasmid such as pUC19. The
chlamydial genomic library consisted of a total of 1,600
white colonies (,-galactosidase negative), which has a >99%
probability of being complete if the chlamydial genome size
is 1,450 kb (8). Each recombinant was inoculated into a well
of a 96-well microtiter plate containing LB and ampicillin
and incubated overnight without agitation in a wet box at
37°C; glycerol was added to 25% before the entire microtiter
plate was frozen.
Whole-cell screen. Our whole-cell screening technique is a
modification of the technique used successfully by Isberg
and Falkow (17) to identify the Yersinia pseudotuberculosis
invasin gene. The recombinant E. coli clones which consti-
tute the chlamydial library were assayed individually for
adherence to eukaryotic cells. All recombinant JM109 and
control strains were inoculated directly from freezer stocks
into LB containing ampicillin (500 ,ug/ml) and incubated with
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agitation at 37°C until mid-log phase, as measured by optical
density (A660 of c0.500). The bacteria were pelleted in a
microcentrifuge tube, and each strain was resuspended to
108 bacteria per ml in Eagle's MEM containing 10 mM
HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic
acid) and ampicillin (500 ,ug/ml) but without fetal calf serum.
For a multiplicity of infection of 50:1, 0.1 ml of each bacterial
suspension was added to a subconfluent monolayer of ap-
proximately 2 x 105 eukaryotic cells in a 24-well culture
plate. The cultures were incubated at 35°C for 1.5 to 2 h and
shaken by hand every 15 min, in accordance with the
procedure used in our laboratory for chlamydial infections
(16, 33). After the attachment period, the monolayers were
washed 5 to 10 times with sterile Hanks' balanced salts
solution (HBSS), fixed with methanol for 2 min, and stained
with Giemsa. The number of adherent bacteria per cell on 50
randomly chosen eukaryotic cells was determined by light
microscopy with a 40x objective. Recombinants were
scored as positive if an average of 25 bacteria attached per
eukaryotic cell and none adhered to the tissue culture vessel.
Both the negative control, nonadherent JM109(pUC19), and
the positive control, piliated adherent E. coli ORN 115
(courtesy of P. Orndorff [32]), were included whenever the
screening assay was performed.
Invasion assay. Recombinants selected as positive by the
initial whole-cell screen were tested for invasion of eukary-
otic cells by the gentamicin protection assay (6). Following
the 2-h attachment period and extensive washing of the
monolayers, gentamicin was added to 50 ,ug/ml in HBSS and
the cultures were incubated at 35°C for an additional 1 h.
Then the gentamicin solution was removed from the mono-
layers, the monolayers were washed with HBSS, and the
infected eukaryotic cells were detached from the microtiter
well with 0.1% EDTA in HBSS (without Ca2" or Mg2"). The
eukaryotic cells were lysed in 1% Triton X-100 in HBSS; the
bacteria were pelleted in a microcentrifuge and then plated
onto LB plus ampicillin (200 ,ug/ml). Each resulting colony
should represent one surviving bacterium which presumably
invaded the eukaryotic cells.
Suspicious that some of the survivors represented false
positives, i.e., bacteria not killed by gentamicin by virtue of
their protected location in between and underneath the
eukaryotic cells, the gentamicin assay was modified to be
performed on eukaryotic cells in suspension. The washed
infected monolayers were detached from the plastic micro-
titer well by addition of 0.1% EDTA in HBSS (with
agitation), pelleted at 500 x g, resuspended in HBSS with
gentamicin (50 ,ug/ml), and incubated in suspension at 35°C
for 1 h. The eukaryotic cells were pelleted again and lysed,
and the bacteria were plated as above.
Membrane-binding screen. An alternative screening
method was designed in case the chlamydial adherence
determinants expressed in the recombinants might not be
translocated to the outer membrane of E. coli. McCoy and
HEC-1B cells radiolabeled with 0.5 mCi of Tran35S-label per
150-cm2 flask (ICN Biomedicals, Inc.) were subjected to
hypotonic lysis (31), and the radiolabeled eukaryotic mem-
branes were isolated on Percoll gradients (density, 1.05
g/ml). Following velocity centrifugation at 100,000 x g for 1
h at 4°C, the purified, radiolabeled membranes were sus-
pended in phosphate-buffered saline containing 0.5% 3-
[(3-cholamidopropyl)-dimethyl-ammonio]-1-propanesulfonate
(CHAPS) (28).
The recombinants and the negative control, E. coli
JM109(pUC19), were inoculated onto nitrocellulose filters
placed on LB-ampicillin plates and incubated at 37°C for 12
h. The filters were removed the next day, spotted with 5 pAl
of a crude preparation of EB (the positive control), and
treated with CHCl3 fumes for 15 min to permeabilize the
bacterial membranes. The filters were rinsed twice at 37°C
with gentle agitation with blot buffer (50 mM Tris, 15 mM
NaCl, 1 mM CaCl2, 10 mM MgCl2) containing protease
inhibitors (200 ,uM phenylmethylsulfonyl fluoride, 1 ,uM
pepstatin, and 1 ,uM leupeptin), blocked with 5% nonfat dry
milk in blot buffer for 1 h, and incubated for 1.5 to 2 h with
106 cpm of 35S-labeled membrane (as determined by scintil-
lation counting) in blot buffer containing 0.5% CHAPS (28).
The filters were rinsed three times with blot buffer, air dried,
covered with Saran Wrap, and placed on film for autoradi-
ography (X-OMAT AR; Eastman Kodak). Treatment with
fluors was not required for enhancement of the signal.
Agarose gel electrophoresis and Southern blots. Restriction
enzyme digests, agarose gel electrophoresis, and Southern
blots were performed as described by Maniatis et al. (29),
except the plasmid probes were labeled with dUTP-biotin by
the random primer method (7). After the standard hybridiza-
tion procedure at 65°C (29), the biotinylated probes were
detected by using a streptavidin-alkaline phosphatase conju-
gate (24).
Curing the plasmid. To determine whether loss of the
adherent phenotype could be correlated with loss of the
recombinant plasmid before further characterization and
subcloning proceeded, the recombinant plasmid was cured
from the host E. coli by transformation into the same strain
of a second plasmid, pHSS6 (Kanr [38]), incompatible with
pUC19. The pHSS6 plasmid carries different selectable
markers than pUC19; therefore, under only kanamycin
selection, pHSS6 will supplant the Apr recombinant plasmid
after many generations. pHSS6 was transformed into the
recombinant strains (JM109) by electroporation (1). The new
transformants were initially selected on LB plates supple-
mented with ampicillin (200 ,ug/ml) and kanamycin (50
,ug/ml). Subsequently, several transformants were chosen,
grown to lag phase in LB broth containing only kanamycin
(50 jig/ml), and repeatedly subcultured into fresh LB-kana-
mycin. The recombinants [JM109(pUC19 + chlamydial
DNA, pHSS6)] were subcultured by this method three times
a day for 5 days. When the phenotype was reexamined, there
were no detectable Apr colonies remaining (<0.01%), and
these bacteria were tested for adherence in the whole-cell
binding assay.
SDS-PAGE and maxiceli analysis. Total protein concentra-
tions were determined by the bicinchoninic acid microassay
(Pierce). Samples were subsequently heated at 100°C for 10
min in 0.12 M Tris-HCl (pH 6.8)-2% (wt/vol) SDS-2%
(vol/vol) ,B-mercaptoethanol-20% (voLvol) glycerol-0.01%
(wt/vol) bromophenol blue. Solubilized proteins were re-
solved by SDS-polyacrylamide gel electrophoresis (PAGE)
with a 15% (wt/vol) polyacrylamide separating gel and a 4%
stacking gel, essentially as described by Laemmli (27).
Protein profiles were visualized by staining with Coomassie
brilliant blue.
Plasmid-encoded polypeptides were radiolabeled by maxi-
cell analysis by a modification (41) of the original method of
Sancar et al. (37). Since strain JM109 was found to be
sensitive to UV irradiation (57.6 J/mm2), the initial recom-
binants were used for these studies. Briefly, recombinants
and controls were incubated in M9 broth, supplemented with
0.5% casamino acids and 0.4% glucose, to an A6. of 0.350 to
0.500 and then UV irradiated. These cultures were incubated
overnight in the presence of cycloserine (200 ,ug/ml) to
eliminate any viable bacteria. The next day, the bacteria
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were washed, starved for 60 min at 37°C in M9 medium
without casamino acids, and subsequently incubated at 37°C
with either 25 ,uCi of Tran35S-label (ICN Biochemicals) or 25
,uCi of '4C-mixed amino acids (New England Nuclear) for 1
or 4 h, respectively, to label newly synthesized proteins. The
maxicell products were resolved by SDS-PAGE. Following
fluorographic enhancement with Enlightening (New England
Nuclear) radiographic enhancer for 15 min, the gels were
dried (except for 20% polyacrylamide gels) and examined by
autoradiography with X-ray film (X-OMAT AR; Eastman
Kodak).
Production of polyclonal antisera and Western immunoblot
analysis. C. trachomatis serovar E antisera were generated
in female New Zealand White rabbits weighing 7 to 7.5 lb
(ca. 3 to 3.4 kg). A Renografin-purified preparation of
serovar E EB served as one inoculum, and EB which had
been freshly treated with 10 mM dithiothreitol (DTT) in 2x
sucrose-phosphate-glutamine buffer (2SPG) for 60 min at
37°C were used as a separate inoculum. DTT reduction was
used to expose subsurface components perhaps masked by
the tightly disulfide-bonded EB envelope. On examination
by Macchiavello stain, the DTT-treated EB appeared blue,
like RB (12). Both preparations were suspended in 2x
sucrose-phosphate-glutamine buffer to a final concentration
of 109 EB per inoculum. The immunization schedules in-
volved six initial intravenous injections over a 2-week pe-
riod, followed by monthly subcutaneous boosts over a
6-month period. The polyclonal sera were collected approx-
imately 10 days after each subcutaneous boost.
Following SDS-PAGE, protein was electrophoretically
transferred to nitrocellulose (0.2-jim pore size; Schleicher &
Schuell) as described by Towbin et al. (46). Prior to blotting,
antichlamydial antisera were adsorbed five times against
JM109(pUC19) whole cells to reduce background cross-
reactive epitopes and subsequently diluted 1:200 in phos-
phate-buffered saline plus 0.05% Tween 20. An alkaline
phosphatase-conjugated anti-rabbit immunoglobulin G (IgG;
Sigma Chemical Co.) was used for Western detection as
described by Blake et al. (3).
Monospecific, polyclonal antiserum against the -82-kDa
protein was generated in a female New Zealand White
rabbit. Total E. coli JM109(pPBW58) protein was resolved
by preparative 8% polyacrylamide SDS-PAGE and visual-
ized by staining with Coomassie brilliant blue, and the
-82-kDa band was excised. Protein was eluted from the gel
slices into 1 M NaCl with an electrophoretic concentrator
(LKB 2014 Extraphor; Pharmacia-LKB), dialyzed exten-
sively against 10 mM potassium phosphate buffer (pH 7.0,
4°C), lyophilized, and stored in 5% (wt/vol) sucrose at
-70°C. The preparation contained no detectable level of
lipopolysaccharide (LPS) as determined by the 2-keto-3-
deoxyoctulosonic acid microassay of Karkhanis et al. (20)
and was diluted in saline prior to injection. Two intravenous
injections, each containing 51 jig of protein, were adminis-
tered on days 1 and 5. Subsequent subcutaneous injections
of 34 jig of protein, in Freund's incomplete adjuvant, were
administered twice weekly beginning on day 15. The IgG
fraction was purified from collected immune serum with a
Rec-protein G affinity column (Zymed Laboratories, Inc.),
adsorbed against E. coli JM109(pUC19), and diluted 1:1,000
for Western blot analysis as described above.
TEM. The procedures for preparation of samples for
transmission electron microscopy (TEM), embedding in
Epon-Araldite resin, and staining of the ultrathin sections
were the same as described previously (52). The sections
were examined on a Philips 201 electron microscope oper-
ating at 60 kV.
RESULTS
Whole-cell screen. A functional screening method was
used to identify possible chlamydial adherence determinants
from a genomic library by testing whether the presence of
expressed chlamydial genes inserted into pUC19 could make
a nonadherent E. coli strain adhere to eukaryotic cells.
Examination of Giemsa-stained infected monolayers by light
microscopy (Fig. 1) allowed us to pay particular attention to
the pattern of attachment of the adherent bacteria. For any
recombinant to be considered adherent, it had to be attached
to the eukaryotic cells and not to the plastic surface of the
culture vessel, and an average of .5 bacteria had to be
attached per eukaryotic cell. These criteria were determined
by assessing the attachment patterns of a positive control,
piliated E. coli ORN 115 (Fig. 1A), and of the negative
control, JM109(pUC19), which rarely if ever attached (Fig.
1B). Although attachment of the piliated E. coli is mediated
by a different mechanism than that in the nonpiliated recom-
binants, the attachment pattern of a known adherent E. coli
strain served to define the criteria for distinguishing true
adherence from "nonspecific trapping."
Of the 1,600 recombinants screened individually on Mc-
Coy cells, 30 to 40 recombinants were initially recorded as
positive. Following a second screening, 25 recombinants
were selected for further screening on the human endome-
trial epithelial cell line HEC-1B. The level of adherence
increased in nine of these recombinants to an average of 10
to 15 bacteria per HEC-1B cell (Fig. 1C and D). The
adherent recombinants were notably concentrated at the
leading lamellapodial edge and thin processes of eukaryotic
cells (Fig. IC). Often there were large clusters of adherent
bacteria on a single eukaryotic cell. We believed that this
might be a eukaryotic cell cycle phenomenon for two rea-
sons. All inocula had been carefully examined prior to
addition to the monolayers, and clumping of the bacteria was
not observed. Second, although the bacteria were in log
phase, preliminary experiments had demonstrated that no
appreciable bacterial cell division occurred during the adher-
ence period when serum was omitted from the medium.
Examination by TEM (Fig. 2) demonstrated that some
recombinant E. coli were attached to indented electron-
dense regions of the polarized epithelial plasma membrane,
which resemble coated pits (Fig. 2D), but none appeared to
be wholely within the cytoplasm.
Do the adherent recombinants enter epithelial cells? A
standard invasion assay with gentamicin is based on the
premise that the antibiotic does not readily penetrate eukary-
otic cells. Therefore, gentamicin-sensitive bacteria are pro-
tected only if they have invaded eukaryotic cells. Initial
results from the gentamicin assay found survivors of all
adherent recombinant strains tested, suggesting that all were
capable of invading the epithelial cells. However, TEM
examination demonstrated that the bacteria were located in
protected, extracellular niches, in between and underneath
epithelial cells (data not shown). When the invasion assay
was modified by adding gentamicin to a suspension culture
of the infected epithelial cells, there were no survivors.
Thus, none of the adherent recombinants appeared to enter
the host cell.
Membrane-binding screen. An alternative screening meth-
od was undertaken to expose putative chlamydial adhesins
which may not have been properly assembled on the surface
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FIG. 1. Light photomicrographs of the whole-cell screen. (A) Positive control, piliated E. coli ORN 115; (B) negative control,
JM109(pUC19); (C and D) adherent recombinants incubated with HEC-1B cells for 2 h at 37°C and stained with Giemsa. Magnification, X400.
of E. coli, as required in the whole-cell screen. This ap-
proach involved permeabilization of the membrane of the
recombinant E. coli with CHC13 and subsequent incubation
with radiolabeled eukaryotic membranes. Crude prepara-
tions of McCoy cell membranes were solubilized in several
different detergents: Triton X-100, octylglucoside, and
CHAPS. Comparison of the signals from the positive con-
trol, C. trachomatis serovar E EB, and the negative control,
JM109(pUC19), demonstrated that CHAPS gave the best
signal-to-background ratio. In addition, the divalent cations
Ca2" and Mg2" were necessary for maximum signal. The
entire library was screened with intrinsically 35S-labeled
McCoy cell membranes and subsequently with 35S-labeled
HEC-1B membranes, and five recombinants were consid-
ered to be positive (Fig. 2F).
Only two recombinants were clearly positive by both
screening methods, but this was not surprising since the
location of expressed chlamydial adherence determinants in
different E. coli compartments may affect binding function.
The whole-cell screen appeared to be the more sensitive
approach but was dependent on outer membrane localization
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FIG. 2. TEM photomicrographs of piliated E. coli ORN 115 (positive control) (A) and E. coli recombinants (B to E) attached to McCoy
cells (A and B) and polarized human endometrial epithelial cells (C through E). A darkly staining invagination, suggestive of a coated pit, is
visible in panel D. (F) Autoradiograph of a membrane-binding screen; the positive control, C. trachomatis (EB), and a positive recombinant
(+) are indicated by arrows. The remainder of the spots are recombinants which are negative for this screen. Magnifications: (A) x28,000;
(B) x18,000; (C) x50,000; (D and E) x150,000.
coli and could be compromised by nonspecific "stickiness"
from overexpression of the proteins. Alternatively, it was
possible that the chloroform permeabilization step in the
membrane-binding assay altered the configuration of struc-
turally sensitive domains necessary for a ligand-receptor
interaction. Conversely, one or both methods may have
selected for different characteristics than were originally
sought, such as binding by charge phenomena versus spe-
cific adhesion. Recombinants positive by each assay were
chosen for further examination.
Southern blot analysis of positive recombinants. Examina-
tion of selected recombinant plasmids by Southern blot
verified that the positive recombinants contain chlamydial
DNA sequences. Excision of the inserted sequences by
PvuII digestion followed by separation on an agarose gel
revealed that the recombinant plasmids contain inserts vary-
ing from 2 to 6.7 kb in length. Southern blots of the gel with
Sau3AI-digested total chlamydial DNA as a probe confirmed
that the inserts are chlamydial in origin (data not shown).
Southern hybridizations of the recombinant plasmids to a
BamHI digest of C. trachomatis serovar E DNA demon-
strated that the chlamydial sequences on the plasmids are
from different BamHI fragments of the chlamydial genome;
four examples are shown in Fig. 3. Each lane represents
hybridization with a different recombinant plasmid. In each
case, the number of chlamydial DNA fragments hybridizing
to the recombinants is one greater than the number of
BamHI sites in the insert of the recombinant plasmid,
suggesting that the chlamydial inserts in the recombinant
plasmids are from a contiguous portion of the chlamydial






FIG. 3. Southern hybridization of biotinylated recombinant plas-
mids to C. trachomatis serovar E DNA. Lanes 1, 2, 3, and 4 are
separate Southern blots of BamHI-digested total C. trachomatis
serovar E DNA, transferred from the same 1% agarose gel. Each
lane of chlamydial genomic DNA was hybridized with a different
recombinant plasmid. The number of chlamydial BamHI fragments
hybridizing to the recombinant plasmid probes is equal to the
number of BamHI sites in the plasmid plus 1, suggesting that each
insert is a contiguous portion of the chlamydial genome. The lane
designated MW is a photograph of the ethidium bromide-stained size
markers, a mixture of EcoRI-digested lambda and a HinclI and
Hindlll double digest of lambda.
genome. For example, the recombinant plasmid probe used
in lane 1 does not have a BamHI site in the chlamydial insert
and thus hybridized to a single BamHI fragment of chlamyd-
ial genomic DNA, whereas in lane 3, a single BamHI site in
the insert of the recombinant plasmid results in hybridization
to two chlamydial fragments. Finally, Southern analyses of
the inserts of various positive recombinants probed with
inserts from other positive recombinants have not demon-
strated any shared sequence, although all combinations have
not been tested.
Chiamydial proteins expressed by recombinants. A brief
summary of certain characteristics of three recombinants
examined to date is shown in Table 1 to illustrate the
diversity within the library and, thus, the potential for
examining what may be multiple attachment mechanisms.
Twenty selected recombinants which exhibited varying de-
grees of attachment by one or both screening methods
produced a combination of three novel proteins--82, 28,
and 18 kDa-shown by staining with Coomassie blue. In-
tensely stained bands of 28, 55, and approximately 82 kDa
(±7 kDa) are visualized in E. coli JM109(pPBW58) (Fig. 4A,
lane 3). It is presently difficult to designate an accurate
molecular mass for the large polypeptide; it often migrates as
a doublet and is susceptible to proteolytic breakdown.
JM109(pPBW58) is reproducibly adherent by both screening
assays, whereas JM109(pPBW57) (Fig. 4, lane 4) exhibits
only minimal adherence in the whole-cell assay and pro-
duces only a 55-kDa protein. Unlike the 28- and -82-kDa
proteins, which are consistently produced at a high level of
expression, the appearance of the 55-kDa protein is often
difficult to reproduce. Continued examination revealed that
production of this protein varies with growth conditions,
such as temperature, nutrient source, phase of growth, and
ampicillin concentration. For example, the first four lanes of
Fig. 4A are from E. coli grown in the presence of 200 ,ug of
ampicillin per ml; the last two lanes show E. coli grown in
the presence of 500 ,ug of ampicillin per ml. The higher





Insert size (kb) of plasmid 5.8 2.2 6.7
Result in functional assaysa
Whole-cell screen - + +++
Membrane-binding screen +++ - +
Protein(s) detected (kDa)
Coomassie stain of SDS- 18 (weak) 55 28, 55, -82
PAGE gels
Western blot with anti- - - 18, -82
EB
Western blot with anti- - - 28, -82
DTT-EB
Maxicell analyses 35 (18?) NDb 28, -82 (18?)
a Results graded from strongly positive (+++ +) to negative (-).
b ND, not determined.
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pPBW56, pPBW57, or pPBW58) compared with the E. coli host
strains [JM109 and JM109(pUC19)]. Each lane was loaded with 25 to
30 ,g of total bacterial protein. The migrational values of the novel
protein bands (-82, 55, 28, and 18 kDa; arrowheads) were obtained
by extrapolation from standard curves of low-range molecular
weight markers (Bio-Rad and Pharmacia; correlation coefficients,
-0.91). The numbers on the left indicate apparent molecular masses
in kilodaltons. The polyclonal antisera used in the Western blots (B)
were generated against C. trachomatis serovar E EB (anti-EB) or
EB pretreated with 10 mM DTT (anti-EB-DTT).
concentration of ampicillin resulted in production of a 55-
kDa protein in the host E. coli JM109(pUC19) (Fig. 4A, lane
5). Therefore, the 55-kDa protein appears to be an E. coli
protein and is perhaps involved in stress response. We
recognize that production of this protein may contribute to
minimal levels of nonspecific attachment in the whole-cell
screen; however, (i) JM109(pUC19) grown in the presence of
ampicillin (500 Fxg/ml) is consistently nonadherent and (ii)
JM109(pPBW58) is consistently adherent regardless of the
presence or absence of abundant 55-kDa protein. Following
exposure to chloroform, JM109(pPBW56) (Fig. 4A, lane 6)
exhibits a striking affinity for eukaryotic membranes but is
nonadherent in the whole-cell screen. The presence of an
18-kDa protein is consistently observed, although at a lower
level of production relative to the 28-kDa and -82-kDa
proteins.
Selected recombinants were examined further for recog-
nition of novel proteins by C. trachomatis serovar E poly-
clonal antisera (Fig. 4B). One antiserum was generated
against EB, and the other antiserum was generated against
EB pretreated with DTT (anti-DTT-EB antiserum) to expose
subsurface components that may be masked by the tightly
disulfide-bonded EB envelope. The -82-kDa protein is
strongly recognized by both antisera [E. coli JM109
(pPBW58), Fig. 4B, lanes 2 and 5), but the 28-kDa protein is
detected only by the anti-DTT-EB antiserum (lane 5). As
expected, the 55-kDa protein is not reactive against these
preadsorbed antisera. E. coli JM109(pPBW58) also produces
an 18-kDa protein which is recognized only by Western
blotting with anti-EB serum (Fig. 4B, lane 2). The 18-kDa
protein produced by E. coli JM109(pPBW56) is not detected
by either antiserum, which suggests two separate 18-kDa
proteins, one detectable by staining with Coomassie blue,




























FIG. 5. Autoradiographs of maxicell analyses of recombinant
plasmids. (A) "S-labeled proteins separated by 15% polyacrylamide
SDS-PAGE. (B) 14C-labeled proteins separated by 20% polyacryl-
amide SDS-PAGE. Positions of the protein standards are shown by
the small arrows. Beta-lactamase is visible as a doublet at -31 kDa
in all the samples. Approximately 100,000 cpm of sample was loaded
in each lane of both gels. The larger arrows point out polypeptides
of interest. The -82- and 28-kDa polypeptides are clearly visible in
lane pPBW58 in both panels A and B, but the 55-kDa protein is not
visible in either panel A or B. pPBW58* indicates recombinant E.
coli clones which were transformed with pPBW58 but lost the
adherence phenotype; these nonadherent recombinants produce
less of the 28- and -82-kDa proteins, as determined by maxicell
analysis, than adherent recombinants containing pPBW58.
pPBW56, as suggested by Western analysis, may encode an 18-kDa
protein that is not visible in panel A and difficult to distinguish in
panel B. However, a 35-kDa polypeptide is clearly visible when cells
are labeled with [35S]methionine.
The antigenic recognition of the 18-, 28-, and -82-kDa
proteins by chlamydial antisera is encouraging, but to ascer-
tain their origin from chlamydial gene sequences, maxicell
analyses were conducted with E. coli JM109 recombinants
carrying pPBW56 and pPBW58 (Fig. 5). With Tran35S-label
(70% 35S-labeled methionine and 15% 35S-labeled cysteine
[ICN Biochemicals]; Fig. SA), it is clearly evident that the
28- and -82-kDa proteins originate from the chlamydial
plasmid inserts (lanes 1 and 2). There are some additional
bands, particularly a 35-kDa protein from E. coli JM109
(pPBW56) (Fig. 5A, lane 4), which are not detectable by
Coomassie stain or Western blot. The 43-kDa band visual-
ized in E. coli JM1O9(pPBW58) maxicells most likely repre-
sents a specific proteolytic cleavage product of the -82-kDa
protein; radioanalytic imaging and analysis (Ambis) of repet-
itive experiments consistently show that the amount of the
43-kDa protein coincides quantitatively with the amount of
-82-kDa protein produced.
Since some plasmid-encoded proteins may be Met and
Cys deficient, the maxicell analysis was also conducted with
a mixture of 14C-L-amino acids (Fig. SB). E. coli JM109
(pPBW58) (lanes 1 and 2) shows intense signals for the
28-kDa and -82-kDa proteins, and a weak signal is detect-
able in the 18-kDa migrational range. Convincing evidence of
plasmid origin for the 18-kDa protein(s) awaits sequence
analyses, which are currently in progress.
To address the possibility that the expressed proteins
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FIG. 6. Coomassie-stained SDS-polyacrylamide gel (A) and Western blot (B) of E. coli JM1O9(pUC19), recombinant E. coli
JM109(pPBW58), C. trachomatis serovar E EB and RB, LGV serovar L2 EB, and C. psittaci Cal-10 EB. Each lane was loaded with 25 to
30 jig of total bacterial protein. The numbers on the left indicate molecular masses in kilodaltons. Polyclonal, monospecific antiserum against
the -82-kDa protein from JM109(pPBW58) was used for Western detection.
and nucleic acid probes are being generated. Particular
emphasis is given to the newly described high-molecular-
mass protein. Monospecific antiserum was generated against
the -82-kDa protein from JM1O9(pPBW58), eluted from
SDS-PAGE gels. As shown in Fig. 6, the antiserum specif-
ically recognizes a protein of similar size in highly purified C.
trachomatis serovar E EB and RB (Fig. 6B, lanes 3 and 4),
lymphogranuloma venerum serovar L2 (lane 5), and C.
psittaci Cal-10 (lane 6).
Curing the plasmid. Although the whole-cell screen was
conducted on the freshly generated recombinant library
(three passages in broth culture), one early observation for
E. coli JM1O9(pPBW58) was that a combination of multiple
passages and freeze-thaw cycles resulted in decreased per-
centages of the adherent population and much lower expres-
sion of the 28- and -82-kDa proteins [E. coli JM109
(pPBW58*), Fig. 5A and B]. Plasmid preparations do not
indicate the presence of a contaminating plasmid. It is
presently unclear whether this represents some type of
transcriptional or translational regulation that reduces the
level of expression of the chlamydial proteins, but a corre-
lation between adherence to whole cells and the amount of
recombinant protein produced is evident. The addition to
log-phase E. coli JM1O9(pPBW58) cultures of 1 mM isopro-
pylthiogalactoside, which induces the lac promoter, has no
obvious effect on the level of expression of the 28- or
-82-kDa protein.
Two methods were used to link the adherent phenotype of
recombinant JM1O9(pPBW58) with the presence of the plas-
mid pPBW58. In the first method, pPBW58 was cured from
the recombinant, with concomitant loss of the adherent
phenotype. The original recombinant was transformed with
pHSS6, which is incompatible with pPBW58; selection for
pHSS6 (Knr) resulted in loss of pPBW58 from the strain as
well as loss of the ability to attach to epithelial cells. In the
second method, the purified plasmid pPBW58 was reintro-
duced by electroporation into E. coli JM109; recombinant
progeny had acquired the adherent phenotype and produced
28- and -82-kDa proteins at levels comparable to those in
the original recombinant.
Further analysis of recombinant E. coli JM109(pPBW58).
Recombinant E. coli JM1O9(pPBW58) is an obvious candi-
date for additional studies for several reasons: (i) it is
consistently positive in both binding assays, which corre-
lates with the presence of the plasmid; (ii) it contains a large
chlamydial insert (6.7 kb); and (iii) it produces -82- and
28-kDa recombinant chlamydial proteins, and possibly one
of 18 kDa, the relative amounts of which are reduced in
nonadherent variant strains. E. coli JM1O9(pPBW56), which
is only positive in the membrane-binding assay, also con-
tains a large insert of 5.8 kb, but may be deficient in the
ability to accommodate chlamydial proteins in a native,
functional form. Restriction mapping to date shows little to
no identity between pPBW56 and pPBW58, providing some
support to the possibility of having cloned two separate
genes encoding 18-kDa proteins.
Recognizing that the nonspecific stickiness of E. coli
recombinants expressing chlamydial gene products could be
a major factor in the results of the screening assays, the
binding of recombinant JM1O9(pPBW58) to host cells was
tested under various parameters known to affect the binding
of C. trachomatis serovar E to the same host cells, including
(i) reduced adherence at 4°C, (ii) reduced adherence in the
absence of Ca2" and Mg2", (iii) reduced adherence in the
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presence of the polyanion dextran sulfate, (iv) reduced adher-
ence on exposure of the bacteria to trypsin (10 jig/ml), (v) no
change in adherence when the bacteria are rendered nonviable
by sodium azide (0.02%) treatment for 15 min at 37°C, and (vi)
adherence to rabbit aortic endothelial cells. In all cases, the
binding specificity of JM109(pPBW58) paralleled that of C.
trachomatis, whereas the binding of the positive control,
piliated E. coli ORN 115, did not mimic the pattern of C.
trachomatis binding in every instance. In addition, previous
studies in our laboratory with primary human endometrial
gland epithelial cells (HEGEC) have shown a differential sus-
ceptibility to chlamydial adherence which appears to be mod-
ulated by hormone exposure (30). Tissue obtained from pa-
tients in the proliferative phase (estrogen dominant),
maintained in medium containing physiological concentrations
of estrogen, was able to attach significantly greater numbers of
chlamydiae than secretory-phase (progesterone dominant) tis-
sue. Binding of JM109(pPBW58) to each hormone-responsive
cell type has been examined in one experiment to date. There
was essentially no difference in the numbers of recombinant
bacteria adherent to estrogen-dominant HEGEC and progest-
erone-dominant HEGEC on a per-microscope-field basis, even
though the cell density of estrogen-dominant HEGEC was less
than that of progesterone-dominant HEGEC. However, the
pattern of distribution of adherent bacteria was strikingly
different. At least five or more JM109(pPBW58) cells were
bound to susceptible estrogen-dominant HEGEC, whereas
essentially only one bacterium was attached to susceptible
progesterone-dominant cells.
JM109(pPBW58) in suspension and attached to HEC-1B
cells was analyzed by indirect immunofluorescence with
polyclonal anti-EB or anti-DTT-EB antibodies and then with
fluorescein isothiocyanate-conjugated, second-affinity goat
anti-rabbit IgG antiserum. There was no obvious specific
labeling of the recombinant E. coli surface even though the
bacterial outer membrane was perturbed by EDTA and
exposed to lysozyme. It is possible that chlamydial proteins
are masked by E. coli components, such as LPS, and/or that
the interaction with the epithelial cell surface triggers expo-
sure of functional epitopes. Alternatively, the antichlamydial
antisera may not contain antibodies against surface-accessible
epitopes. It should be noted that the polyclonal anti-
chlamydial antisera used in these studies do not block ad-
herence of infectious EB to target host cells. An initial
experiment (data not shown) in which the inner and outer
membrane of E. coli were separated by isopycnic sucrose
gradient centrifugation (a modification of the method of Ito et
al. [18]) indicates that the -82-kDa protein is present in the
outer membrane. The 28- and 18-kDa proteins appear to be
associated with whole membrane prior to separation; how-
ever, the extent of this association, particularly in the pres-
ence of EDTA, is presently not clear and is under further
investigation.
DISCUSSION
C. trachomatis is an adept bacterial parasite, as demon-
strated by its high incidence in humans. In the United States,
C. trachomatis genital infection is considered the most preva-
lent sexually transmitted disease, and in developing countries,
C. trachomatis eye infection affects an estimated 500 million
people. As an intracellular pathogen, infectious chlamydial EB
must attach to and enter host cells to successfully initiate
infection. How does a nonmotile, nonpiliated, negatively
charged, metabolically inert EB adhere to host cells?
Lacking motility, chlamydiae must rely on Brownian
motion and fluid currents to carry them to the host cell. TEM
observations have suggested that Chlamydia spp. initially
attach to the tips of microvilli, move down the length of the
microvilli, and are internalized at the apical surface of the
epithelial cell. The initial association with the tips of the
microvilli is probably a consequence of reduced electrostatic
repulsion between the negatively charged EB and the nega-
tively charged yet small-diameter microvillus tip, compared
with the relatively large expanse of negative charge found at
the apical surface of the host cell (49). Originally, Hatch et
al. (14) proposed that electrostatic interactions mediate the
binding of chlamydiae to host cells. Subsequently, Ward (49)
proposed that attractive nonspecific forces, hydrophobic
interactions, and London-van der Waals forces compete
with repulsive electrostatic interaction between the nega-
tively charged surfaces of the EB and eukaryotic cell. The
effect of electrostatic repulsion between the EB and the host
cell surface may be reduced in the presence of divalent
cations, such as Ca2" and Mg2" (14), and polycations, such
as DEAE-dextran (25), more so for the more negatively
charged C. trachomatis serovars A through K than for the
LGV serovars (39). Indeed, in a recent study by Su et al.
(44), negatively charged divergent sequences in exposed
MOMP variable domains II and IV were suggested to
function by electrostatic interactions in the initial binding of
C. trachomatis serotype B to Syrian hamster kidney cells.
Monoclonal antibody binding to the two domains signifi-
cantly blocked attachment of chlamydiae to the host cells,
presumably by interfering with the charge-dependent inter-
actions (43, 44). According to the authors, a conformational
change then occurred in the invariant nonapeptide se-
quences in variable domain IV, resulting in the exposure of
a more specific, cryptic, hydrophobic binding site.
Since these binding studies were performed on Syrian ham-
ster kidney cells rather than on the HeLa 229 cells in which the
chlamydiae stocks were grown, there may be differences in the
net negative charges as well as other surface properties be-
tween different epithelial cell types. An example of this possi-
bility was noted in studies in our laboratory with primary
human endometrial gland epithelial cells (HEGEC [30]), in
which two populations of epithelial cells were distinguished by
the fluorescence activated cell sorter; the one to which C.
trachomatis serovar E bound possessed numerous microvilli
and no obvious extracellular matrix; the second population, to
which the chlamydiae did not bind, were devoid of microvilli
and covered with a dense glycocalyx. Our failure to identify
positive recombinants expressing MOMP by the functional
screening assays might also be explained by the difficulty,
reported by other investigators, of isolating recombinant E. coli
expressing high levels of chlamydial MOMP (42).
Once electrostatic and hydrophobic interactions have
drawn the chlamydiae close (-2 to 9 nm) to the target host
cell, do other interactions involving additional chlamydial
adherence determinants occur, such as specific intermolec-
ular interactions (cl nm) between adhesins and receptors?
Kihlstrom and Majeed (23) have recently reported that C.
trachomatis EB first attach diffusely over the host cell but
are mobilized into clusters before they are internalized. This
observation is reminiscent of Fc receptor-mediated antibody
capping on B-lymphocytes as well as receptor clustering into
coated pits; the latter is part of the process of receptor-
mediated endocytosis, which has been implicated in chla-
mydial uptake (15, 16, 36, 40). If movement of chlamydiae
along the host cell membrane is caused by the directed
movement of a eukaryotic receptor within the apical mem-
brane, it follows that C. trachomatis EB may have a specific
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adhesin(s). Although many of the chlamydial genes which had
been isolated in E. coli have been identified by assaying for
expression of the gene product with antichlamydial antisera,
antiadhesin antibody has not been found. Thus, we used
functional screening methods to identify putative adherence
determinant gene products in recombinant E. coli clones.
These screening methods have identified several recombi-
nants which bind eukaryotic membranes. However, recom-
binants that were adherent in the whole-cell screen could
have their surface properties, such as charge or hydropho-
bicity, altered by the presence of foreign chlamydial proteins
in their outer membrane. For instance, the recombinant E.
coli which produces a chlamydialike LPS associates with
HeLa cells two to five times more than the parental strain.
Strains of E. coli lacking the LPS 0 antigen side chain
demonstrate greater association with intestinal mucosa (35,
50). Likewise, recombinants positive for the membrane-bind-
ing blot may produce chlamydial proteins that have nonspe-
cific membrane affinity. Chlamydial polypeptides of 18 and 27
to 32 kDa (the size of the latter depending on the serovar),
after boiling in SDS, separation by SDS-PAGE, and electro-
phoretic transfer to nitrocellulose, were shown to bind to
isolated, radioiodinated HeLa cell membranes. These pro-
teins were purportedly involved in adherence (10, 21, 51).
Recently, the genes encoding the 18-kDa proteins have
been cloned and sequenced. One gene product has predicted
amino acid homology with eukaryotic histone Hi, and the
encoded protein has a calculated pl of 11.4 (11). The other
gene appears to contain a fusion between two noncontiguous
regions of genomic DNA, and the amino terminus of the
fusion is a chlamydial homolog of the E. coli ribosomal
protein L6 gene (9). Such proteins may have bound the
iodinated membrane via nonspecific electrostatic interac-
tions (11) or, alternatively, may have bound to nucleic acid
still associated with the eukaryotic membranes. Though
some of our positive recombinants are producing novel
proteins of a similar size, the novel proteins do not appear to
be homologous to the chlamydial histone Hi-like protein,
the ribosomal L6-like protein, or the 27- to 32-kDa protein.
Monoclonal antiserum generated against the 27- to 32-kDa
protein and polyclonal serum generated against purified
18-kDa (Hcl) protein (courtesy of T. Hackstadt) did not
react with novel proteins produced by JM109(pPBW56) or
JM109(pPBW58). Likewise, antiserum generated against the
ribosomal L6 homolog did not react with novel proteins
produced by our recombinants, nor did the chlamydial insert
of pCT161/18 (both courtesy of W. Wenman) containing the
ribosomal L6 gene homolog hybridize with our recombinant
plasmids (pPBW56 and pPBW58) on a Southern blot. Fur-
thermore, a polyclonal antiserum which reacts strongly with
MOMP did not react with either JM109(pPBW56) or JM109
(pPBW58). It appears that we may have identified different
chlamydial proteins which may function in chlamydial ad-
herence. Yet the question still remains: are these novel
chlamydial proteins synthesized in E. coli mediating a spe-
cific or nonspecific interaction with eukaryotic membranes?
The increased signal and selectivity demonstrated by our
positive recombinants when HEC-1B epithelial cells re-
placed McCoy cells in the screening assay suggest a certain
specificity of the association. Also, the binding specificity of
JM109(pPBW58) to HEC-1B cells and hormone-responsive
primary HEGEC, which parallels that of C. trachomatis, is
very suggestive of specificity.
The significance of the lack of internalization of the
strongly adherent recombinants is not understood at this
time. Assuming that these recombinants do express chla-
mydial adherence determinants, a number of explanations
are possible, including (i) chlamydiae have several different
adhesins, of which a subset triggers internalization; (ii) the
mechanism of internalization of chlamydiae is size-re-
stricted, excluding the larger E. coli; (iii) the "adhesin"
density on the surface of E. coli is not great enough to trigger
internalization; and/or (iv) possibly some enzymatic action
occurring after adherence is required for internalization.
Clearly, before any chlamydial gene products are described
as adhesins, experiments other than those which establish
some unspecified role in attachment are necessary to dem-
onstrate that the proteins mediate specific interactions with
epithelial cell receptors.
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